United States Pharmaceutical Manufacturing Equipment Market Size was valued at USD 5.6 Billion in 2022. The Pharmaceutical Manufacturing Equipment market industry is projected to grow from USD 5.96 Billion in 2023 to USD 9.95 Billion by 2032, exhibiting a compound annual growth rate (CAGR) of 6.60% during the forecast period (2023 - 2032). The growing need for generics and a rising desire for pharmaceuticals are the main market drivers anticipated to propel the Pharmaceutical Manufacturing Equipment market in the United States.
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
Perishable materials are preserved and dried in laboratory and pharmaceutical settings using lyophilizers, sometimes called freeze dryers. To get the frozen water in the substance to sublime, avoid the liquid phase, and transition straight from a solid to a gas, the process of lyophilization entails freezing the material and then placing it under an intense vacuum. This preserves the material and allows it to be kept dry and preserved for an extended time without becoming bad. The United States market growth is anticipated to expand throughout the projected period due to factors including rising investment in the pharmaceutical industry and initiatives by major market players.
In addition, PCI Pharma Services committed USD 100 million in May 2022 to expand the capabilities and capacity of its production plant in Bedford for sterile lyophilization and aseptic liquid fill-finish technology. In May 2022, OPTIMA invested in a cutting-edge facility to expedite and safely integrate pharmaceutical lines into production. Optima Pharma is extending the efficacious CSPE procedure for the swift and secure initiation of production start-up of integrated filling lines with isolators and freeze dryers. Throughout the projection period, there is likely a rise in investment in the United States for lyophilizers for the drug manufacturing process due to the growing acceptance of biopharmaceutical production equipment over time.
Furthermore, advanced robotics and automation technologies simplify manufacturing procedures, increasing production and efficiency. The total manufacturing time can be decreased by using these technologies to complete repetitive operations quickly and precisely. In the United States pharmaceutical production industry, automation and robotics lessen the need for manual labor for repetitive activities.
This lowers labor costs and reduces the possibility of mistakes, guaranteeing consistent product quality. Modern automation systems are designed to be flexible and easily scalable. This allows pharmaceutical manufacturers to adapt to changing production demands, handle different formulations, and efficiently adjust production volumes as needed. Thus, driving the United States Pharmaceutical Manufacturing Equipment market revenue.
Based on equipment type, the United States Pharmaceutical Manufacturing Equipment market segmentation includes packaging machines, mixing and blending machines, inspection equipment, extrusion equipment, spray drying equipment, milling equipment, tablet compression presses, and filling machines. The packaging machines segment dominated the market mostly. Pharmacies can maintain product quality and compliance with labeling, dosing, and storage requirements by using pharmaceutical packaging machines to shield the finished product from contamination, deterioration, and damage. A drug product's ability to be used safely, effectively, and in compliance with regulations depends on how well and precisely it is packaged. Pharmaceutical packaging machines are becoming increasingly technologically advanced to comply with strict regulatory policies. This is due to the growing incidence of chronic diseases, the aging population, and rising healthcare spending. These factors are creating a demand for novel and diverse drugs.
The mixing and blending machines category are anticipated to be the fastest growing. Granulation is the process of combining small powder particles into bigger granules to minimize segregation and make the granules simpler to handle. Mixing and blending equipment is employed in wet and dry granulation operations to attain the intended particle size distribution and enhance the granules' flow characteristics.
Based on end-product type, the United States Pharmaceutical Manufacturing Equipment market segmentation includes liquid and solid. The liquid category generated the most income. Patients with trouble swallowing pills or capsules may find liquid dose forms more comfortable. Since it is simple to quantify and modify the amount of medicine in each dose, they enable accurate dosing. This is especially crucial for medications that need to be taken precisely or have a limited therapeutic range. Intractable or unstable drugs in solid dosage forms can be synthesized as solutions or suspensions using liquid dosage forms, giving formulators more creative freedom. These factors fuel the market for liquid dosage forms since people prefer them over solid ones.
The solid category is expected to have the quickest rate. Tablets and capsules are oral solid dosage forms that still rule the pharmaceutical industry. Because patients tend to like these forms, pharmaceutical companies invest in machinery capable of producing high-quality solid-dose products efficiently.
Figure 1: United States Pharmaceutical Manufacturing Equipment Market, by End-Product Type, 2022 & 2032 (USD Billion)
Source: Secondary Research, Primary Research, MRFR Database and Analyst Review
During the evaluation period, the United States is anticipated to maintain its market share. The nation is expected to gain a 6.5% market share, according to the latest market projections. Growth in the pharmaceutical manufacturing equipment market is anticipated to be driven by the increased focus on new developments and improvements. As a developed nation, the United States is poised to spearhead market expansion. In addition, there should be profitable chances due to the area's expanding technical improvement. Because people's preferences are moving towards generic medications, the country's growing generic pharmaceutical business is predicted to generate considerable prospects.
The market for pharmaceutical manufacturing equipment is expected to grow even more due to major players in the industry making significant R&D investments to extend their lines of equipment. Alongside these significant market developments, market participants engage in various strategic actions to broaden their market reach. These activities include introducing new equipment types, contractual agreements, mergers and acquisitions, increased investments, and cooperation with other organizations. The pharmaceutical manufacturing equipment sector needs to provide affordable products to grow and thrive in a more cutthroat and dynamic market.
Major United States Pharmaceutical Manufacturing Equipment market players are attempting to increase market demand by investing in research and development operations, including Thermo Fisher Scientific Inc., Pall Corporation, Honeywell, Rockwell Automation, MilliporeSigma, GE Healthcare, and Emerson.
| Report Attribute/Metric | Details |
| Market Size 2022 | USD 5.6 Billion |
| Market Size 2023 | USD 5.96 Billion |
| Market Size 2032 | USD 9.95 Billion |
| Compound Annual Growth Rate (CAGR) | 6.60% (2023-2032) |
| Base Year | 2022 |
| Market Forecast Period | 2023-2032 |
| Historical Data | 2018- 2022 |
| Market Forecast Units | Value (USD Billion) |
| Report Coverage | Revenue Forecast, Market Competitive Landscape, Growth Factors, and Trends |
| Segments Covered | Equipment Type, End-Product Type |
| Countries Covered | United States |
| Key Companies Profiled | Thermo Fisher Scientific Inc., Pall Corporation, Honeywell, Rockwell Automation, MilliporeSigma, GE Healthcare, and Emerson |
| Key Market Opportunities | · Obtaining pharmaceutical production equipment to gain a competitive edge · Rise in personalized medicine equipment |
| Key Market Dynamics | · Growing need for generics · Rising desire for pharmaceuticals |
Frequently Asked Questions (FAQ) :
The United States Pharmaceutical Manufacturing Equipment market size was valued at USD 5.6 Billion in 2022.
The market is projected to grow at a CAGR of 6.60% during the forecast period, 2023-2032.The market is projected to grow at a CAGR of 6.60% during the forecast period, 2023-2032.
The key players in the market are Thermo Fisher Scientific Inc., Pall Corporation, Honeywell, Rockwell Automation, MilliporeSigma, GE Healthcare, and Emerson, among others.
The packaging machines category dominated the market in 2022.
The liquid category had the largest share of the market.
Assistant Manager He holds an experience of about 7+ years in market research and business consulting, working under the spectrum of life sciences and healthcare domains. rahul conceptualizes and implements a scalable business strategy and provides strategic leadership to the clients. his expertise lies in market estimation, competitive intelligence, pipeline analysis, customer assessment, etc. in addition to the above, his other responsibility includes strategic tracking of high growth markets & advising clients on the potential areas of focus they could direct their business initiatives
Get in Touch
© 2024 Market Research Future ® (Part of WantStats Reasearch And Media Pvt. Ltd.)
